Rare diseases
Investigational molecules
Locations
Study of Fianlimab and Cemiplimab for Patients with Untreated Advanced Melanoma
ItalyStudy Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ItalyStudy of Ravulizumab for Adults with Lupus Nephritis or IgA Nephropathy
ItalyStudy on the Effects of Dersimelagon Phosphate for Adults and Adolescents with Erythropoietic Protoporphyria or X-Linked Protoporphyria
ItalyStudy of daily low-dose Temozolomide in patients with advanced neuroendocrine tumors (NETs) who are not eligible for standard treatments due to their health condition
ItalyStudy on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy
ItalyStudy on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
ItalyStudy on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
ItalyStudy on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus
ItalyStudy comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer
ItalyStudy on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma
ItalyStudy on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
